The Food and Drug Administration (FDA) has developed a vaccine developed by Moderna and federal researchers, the second Covid-19 vaccine to gain such approval for emergency use across the U.S.
Emergency authorities will administer the second drug to prevent Covid-19 to the American public within a week, and millions of doses are expected to begin immediately to be distributed to health workers and long-term care residents -time.
The Moderna vaccine is 94% effective in preventing Covid-19, and is authorized in adults 18 and older. The authority comes after it was recommended by the FDA’s advisory panel of independent experts.
“With two vaccines now available to prevent Covid-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing large numbers of measles. ‘hospitals and deaths in the United States every day,’ FDA Commissioner Stephen Hahn said in a statement announcing the emergency authorization.
The vaccine developed by Moderna and the National Institute of Infectious and Infectious Diseases (NIAID) uses messenger RNA technology to incorporate the body into the spike proteins that cover the coronary surface.
“I would expect to see scenes in the arm early next week,” Dr. Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases (NIAID), told NBC earlier today.
Unlike the Pfizer vaccine, Moderna vaccine delivery will be regulated by the federal government, using funding from Operation Warp Speed, the Trump administration’s program to rapidly develop and roll out Covid-19 vaccines and treatments.
The Pfizer vaccine, the first to ban U.S.-authorized Covid-19 last week, will use the same technology. Both companies are expected to apply for full licenses for the vaccines in the coming months. Federal authorities hope to vaccinate 20 million people by the end of the year.
The authorization comes as the first doses of vaccine developed by Pfizer are given to health workers and long-term care residents, after it has been approved by the Pfizer. FDA last week.
Several celebrities have already received the Pfizer vaccine, including vice president Mike Pence and House spokeswoman Nancy Pelosi on Friday. Joe Biden is expected to be vaccinated on Monday.
The Moderna vaccine has at least two distinct advantages over the first vaccine. It needs to be cooled, but it doesn’t need the ultra-cold -70C (-94F) required by the Pfizer vaccine. This means that the vaccine may be easier to carry in rural areas, and more prone to litter. Further, Moderna data show that its vaccine appears to protect people against Covid-19 abuse, when it does not prevent the disease.
The authorization also comes as the virus continues to inflict a terrible toll on Americans. Thursday set a new record for daily deaths, when more than 3,500 Americans contracted the virus in a single day.
An opinion article published in the Journal of the American Medical Association the same week seized the toll: “The U.S. daily mortality rate for Covid-19 deaths is the same as September 11, 2001, attacks, which claimed 2,988 lives, occur every 1.5 days. , or 15 Airbus 320 jetliners, each carrying 150 passengers, colliding daily, ”wrote Dr Stephen Woolf and co-authors.
Authorization, an important achievement for modern medicine, is also a key achievement for Moderna. Prior to approval, the company had no products for use with the FDA. Prior to working on the mRNA vaccine for Covid-19, scientists at Moderna were studying mRNA technology specifically in cancers.
The Moderna vaccine will bring up to 300 million the number of doses that can be given to high – risk groups, 200 million of which are under contract to give Moderna to the federal government.
Because all vaccines require a two-dose “boost” regimen, that means the U.S. will have enough doses to vaccinate 150 million people, if they are capable of one of the most advanced vaccine campaigns. in medical history spread. Moderna relies heavily on subcontracted manufacturers to make millions of doses of the vaccine.
Even with the memorable accomplishment of approving a second vaccine, scientists still need to move forward with more vaccine candidates to harness the manufacturing potential to reach millions more Americans and people around the world. .
That means the authority of the second vaccine will not immediately return to normalcy, as it will take the best of a vaccine year to deliver vaccines and distribute them to hundreds of millions of Americans.
Both images have to overcome high levels of vaccine complaints from a skeptical and tired American public, which has been plagued by misinformation for months. The Moderna vaccine may have an even higher barrier, as the same White House that has leaked Covid-19 misinformation played a role in its development.
The Moderna vaccine was found to be more than 94% effective in preventing Covid-19, in a trial of more than 30,000 patients. Moderna scientists reported two sensory reactions in his experiment, one in the placebo arm and another in a vaccinated recipient.
In the arm of the vaccine, the allergic reaction was more than 60 days after the partner received the vaccine, and was found to be related to an individual medical procedure.